Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC.
Menig-Benzig LS, Stühler V, Mazzola P, Heinrich H, Hofmann U, Widmann N, Bohnert R, Neef SK, Sauter-Meyerhoff C, Schmees C, Fuhr A, Klumpp V, Rausch S, Gürgen D, Mürdter TE, Winter S, Büttner FA, Kruck S, Choffart A, Martins AF, Hennenlotter J, Barcena ML, Vakhrusheva O, Bahlinger V, Fend F, Tsaur I, Bedke J, Schwab M, Schaeffeler E.
Menig-Benzig LS, et al. Among authors: kruck s.
Pharmacol Res. 2025 Dec;222:108057. doi: 10.1016/j.phrs.2025.108057. Epub 2025 Dec 3.
Pharmacol Res. 2025.
PMID: 41349849
Free article.